Fundraising FoxPolaris Partners — 2016 Investments
11 investments dated 2016 · listed companies and verified rows first · show all
Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies aimed at treating autoimmune diseases.
BiotechHealthtechWatertown, US
Metin Kurtoglu(Executive Officer)Omid Farokhzad(Director)Chris Jewell(Executive Officer)inCarsten Brunn(President, CEO & Chairman of the Board)inEmily English(Executive Officer)inBlaine Davis(Executive Officer)in
Board seatAmir Nashat· per SEC Form D · $70M raise · filed Jan 2020
Co-investorsK2 HealthVenturesMaryland TEDCOSchooner CapitalTEDCO+ND CapitalRUSNANO
Daré Bioscience is a female-led biotech company developing treatments for women's health conditions that are overlooked in the healthcare industry.
BiotechDigital HealthDirect to ConsumerFemTechHealthtechSan Diego, US
MarDee Haring-Layton(Chief Accounting Officer)inSabrina Martucci Johnson(Founder & Chief Executive Officer)Christopher D.T. Guiffre(Executive Officer, Director)Gregg Beloff(Executive Officer)Alejandra V. Carvajal(Executive Officer)Adrian Senderowicz(Executive Officer)
Board seatAlan Crane· per SEC Form D · $1 raise · filed Oct 2016
Co-investorsLilly VenturesVenrock
X4 Pharmaceuticals is a biopharmaceutical company developing medicines for people living with rare immune disorders, including chronic neutropenia.
BiotechBoston, US
Mary DiBiase(Executive Officer)inChristophe Arbet-Engels(Executive Officer)inDavid Kirske(Executive Officer)inJohn Volpone(Executive Officer)inMark Baldry(Executive Officer)Adam Craig(Executive Officer, Director)in
Board seatAmy SchulmanTerrance McGuire· per SEC Form D · $50.5M raise · filed May 2017
Co-investorsBain Capital Life SciencesLumira VenturesNew Enterprise Associates (NEA)Partners ResoluteThynk CapitalAdvent Life Sciences+1 more
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.
BiotechDigital HealthHealthtechCambridge, US
PETER M. HECHT(Executive Officer, Director)inMARK G. CURRIE(Executive Officer)inHALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)in
Board seatTerrance G. Mcguire· per SEC Form D · $150M raise · filed Oct 2016
Co-investorsF-Prime CapitalMountain Group CapitalRidgeback CapitalVenrockMaverick Ventures
Sofregen develops silk protein-based biomaterials and medical devices for soft tissue regeneration in aesthetic and surgical procedures.
BiotechHealthtechMedical DevicesNew MaterialsCambridge, US
Milan Kofol(Executive Officer)Doug Sheldon(Director)Anh Hoang(Executive Officer)Howard Weisman(Executive Officer, Director)
Board seatAmir Nashat· per SEC Form D · $9.7M raise · filed Sep 2017
Co-investorsAnzu Partners
B12 offers an AI-powered website builder that generates a complete first draft of a website, online store, portfolio, blog, or web app from a text prompt, which users can then refine via an AI agent or visual editor.
AI & Machine LearningMarketing TechSaaS
Nitesh Banta(Founder)inAdam Marcus(Founder)in
Co-investorsFrancisco PartnersLightbankLux CapitalSuffolk Equity PartnersBrand Capital InternationalFounder Collective+6 more
FloQast provides reconciliation management and workflow automation software for accounting teams, designed by accountants to streamline financial processes and improve productivity.
AI & Machine LearningConsumerEnterprise SoftwareFintechFoodTechSaaS
Mike Whitmire(Founder)inChris Sluty(Founder)inKushal Malde(Head of Financial Control)inCullen Zandstra(Founder)Michael Whitmire(Founder)
Co-investorsAmplify.LAICONIQInsight PartnersLeft Lane CapitalNewView CapitalNorwest Venture Partners+9 more
.png)
Qstream offers a microlearning platform with AI tools that turn existing content into short, scenario-based training courses.
AI & Machine LearningEdTechSaaSBurlington, US
Duncan Lennox(Executive Officer, Director, Promoter)inBranch Price Kerfoot(Director)
BoardHambleton Lord(Director)inShay Garvey(Director)inGaye Bok(Director)Harold Copperman(Director)
Co-investorsDelta PartnersExcel Venture ManagementLaunchpad Venture GroupEnterprise IrelandBantam GroupFrontline Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
1366 Technologies480 BiomedicalAthletes' Performance
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.